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1. Introduction 
Histone phosphorylation is a post-synthetic modi- 
fication involved in the regulation of metabolic pro- 
cess and genetic expression [ 1,2] and associated with 
changes in chromatin structure [3]. 
All histones are phosphorylated but lysine-rich his- 
tones are the most active substrates for cyclic AMP- 
dependent protein kinases [4]. Phosphorylation of 
lysine-rich histone (Hl) has been correlated with the 
rate of cell division in different rat and mouse tumors 
[S]. Phosphorylation is more extensive in rapidly 
growing cells than in non-dividing tissue. Phosphoryl- 
ation is also related to cell maturation, for example, 
to erythrocyte maturation [6] during which time his- 
tone H5 is synthesized. 
The phosphorylation of the histones with protein 
kinases isolated from different mammalian tissues: 
brain, liver, testis and thymus, takes place at specific 
sites of the amino acid sequences, generally located in 
highly basic regions which are major sites of interac- 
tion with DNA [7]. Therefore phosphorylation can 
modulate the histone-DNA interactions. 
This paper deals with the in vitro phosphorylation 
of histones by a cyclic AMP-dependent protein kinase 
isolated from rat pancreas. Histones from various 
sources were used: H2B from rat thymus, H2A (vari- 
ant a) from rat chloroleukemia; the complex H2A- 
H2B from calf thymus; HS from chicken erythrocyte. 
In rat chloroleukemia, histone H2A exhibits a 
polymorphism depending on the nature of the amino 
acid residues at positions 16 and 99 [8]. Three molec- 
ular species of H2A were identified in this tumoral 
Abbreviation: TPCK, Tos-Phe CH,Cl, N-tosyl phenylalanine 
chloromethyl ketone 
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tissue: H2Aa (serine 16 and lysine 99); H2ABl 
(threonine 16 and arginine 99); H2A-02 (serine 16 
and arginine 99). The variant a! which accounts for 
60% of the total H2A is of special interest because of 
a potential site of phosphorylation at serine residue 
in position 16. 
On the other hand, the dimer H2A-H2B is known 
to be a constitutive element of the nucleosome [9] 
in the chromatin structure. It was therefore attractive 
to determine if the sites of phosphorylation were 
identical in the complex and in the individual his- 
tones. 
The phosphorylated histones were hydrolysed 
with trypsin. The 32P-labelled peptides were isolated 
and the sites of phosphorylation determined. Four 
sites of phosphorylation were identified in rat thymus 
histone H2B: two major, at serine residues 32 and 36, 
and two minor, at serine residues 87 and 91 [IO]. 
Two sites of phosphorylation were identified in 
rat chloroleukemia histone H~A-(u at serine residues 
1 and 19. The serine residue at position 16 was not 
phosphorylated. 
Since sequences of rat and calf histones H2A differ 
only by one conservative change at position 16 [8] 
Ser (rat) --+ Thr (calf) which is not a phosphoryla- 
tion site and since rat and calf histones H2B have 
identical primary structures [lo], the histone com- 
plex H2A-H2B was prepared from calf thymus chro- 
matin in order to get a larger amount of substrate for 
our phosphorylation experiments. 
When the dimer H2A-H2B was assayed, phos- 
phorylation took place at the same serine residues 
and to the same extent as in the isolated histones. 
In chicken erythrocyte histone HS, four phos- 
phorylated sites were identified: at serine residues 22, 
29,145 and 166 [ll]. 
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The major phosphorylation sites in all the assayed 
histones are generally located within predicted P-turns 
[ 12,131 and in the basic region of the proteins, which 
is involved in electrostatic interactions with the 
phosphate groups of the DNA. 
(w/w) [ 1 I]. Hydrolysis was stopped by freezing. 
Fractionation of peptic peptides was performed on 
Sephadex G-50 fine (column 150 X 2.5 cm) equili- 
brated and eluted with 0.01 M HCl. The C-terminal 
peptide (peptide Px, 96 residues) was isolated and 
submitted to tryptic hydrolysis as above. 
2. Materials and methods 
An aliquot was taken from each hydrolysate for 
peptide mapping on Whatman 3 MM paper as in [ 191. 
2.1. Preparation of 32P-labelled histones 
The variant a! of rat chloroleukemia histone H2A 
was obtained by ion-exchange chromatography on 
Biorex 70 as in [8]. 
Rat thymus histone H2B was isolated by pre- 
parative electrophoresis on polyacrylamide slab gel 
[ 141. The calf histone complex H2A-H2B was iso- 
lated from histone fraction F2b [ 151 by ion-exchange 
chromatography on Biorex 70 as in [ 161. 
Chicken erythrocyte histone H5 was prepared as in 
[171. 
Histones were phosphorylated by a cyclic AMP- 
dependent protein kinase isolated from rat pancreas. 
The catalytic subunit of this protein kinase was 
obtained, in a highly purified state by chromatog- 
raphy on CM-Sepharose [ 181, 
About 20 mg of each histone (H2A+ H2B, H5) 
and 40 mg of the dimer H2A-H2B were dissolved in 
30 mM Tris-HCl (pH 7.8) containing 12 mM MgC&; 
histone was 0.5 mglml. The mixture was then incu- 
bated for 24 h at 30°C with the purified enzyme 
(l-l .5 pglml) in the presence of0.4 mM [y-32P]ATP. 
The presence of an equimolar histone complex in 
these experimental conditions was assessed by circu- 
lar dichroism spectroscopy (fig.1). Incubation was 
stopped by cooling (4°C) and the incubate was dia- 
lyzed against deionized water (2 X 3 1) for 18 h and 
lyophilized . 
2.2. Enzymatic cleavages of labelled histones and 
15 
5 
- 5 
- 15 
identification of the phosphorylation sites 
Tryptic hydrolysis : 32P-labelled histones and dimer 
H2A-H2B were hydrolyzed for 2 h at pH 8.0 and 
37°C in 0.1 MN-methyl morpholine with TPCK- 
treated trypsin (Worthington) using an enzyme-to- 
substrate ratio of 1:50 (w/w). The hydrolysis was 
stopped by lowering to pH 3.5 with formic acid. 
Pepsin cleavage of histone H5: Alternatively, the 
phosphorylated histone H5 was dissolved in 5% 
formic acid and hydrolyzed for 2 h at 37°C with 
pepsin using an enzyme-to-substrate-ratio f 1:50 
Fig.1. Circular dichroism spectra of calf thymus histones 
H2A (--), H2B (. . .), of a hypothetical non-interacting 
equimolar HZA/HzB mixture (.-.) and of the dimer H2A- 
H2B (-). Histones and dimer were dissolved in 30 mM 
Tris-HCl (pH 7.8) containing 12 mM MgCl, in the presence 
of 0.4 mM ATP. Histone was 0.5 mg/ml and measurements 
were made using a Jobin-Yvon dichrogaph R. J. Mark III 
with a 0.1 mm pathlength cell. The dichroism spectrum of 
the dimer H2A-H2B is characteristic of a true complex 
namely by the [B ] 122 value which accounts for - 10650”. 
This value agrees with that of - 11700” found [30] for 
the dimer H2A-H2B in 25 mM potassium phosphate (pH 
7.0). 
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Fig.2. Elution diagrams of phosphorylated tryptic peptides, fractionated on a Chromobeads P column. Peptides were eluted with 
pyridine-formate and pyridine-acetate buffers used in a pyridine concentration and pH gradient [ 201. Peptides were designated 
by the symbol T and numbered according to their elution volume of the Chromobeads P column. (A) Phosphorylated complex 
H2A-H2B; (B) phosphorylated histone H5 . 
The tryptic hydrolysates were fractionated by ion 
exchange chromatography on a Chromobeads P 
column with pyridine formate and pyridine acetate 
buffers [20]. Fractions of 5.5 ml were collected at 
33 ml/h flowrate. Elution of the peptides was 
monitored automatically by ninhydrin reaction. The 
Sakaguchi reaction was specifically used for the 
detection of the amino terminal peptide N-acetyl- 
Ser-Gly-Arg of histone H2A. 
Fractions containing peptides were pooled, evapor- 
ated and taken into 1 ml 10% acetic acid. The radio- 
activity was then measured on an aliquot (5 /.d) of 
each peptidic fraction after adding 2 ml Bray solution 
[2 11. Fig.2 shows the lution diagrams of phospho- 
rylated tryptic peptides from the dimer H2A-H2B 
(A) and from histone H5 (B). 
The radioactive peptides were located on tryptic 
fingerprints by radioautography, using Kodirex film 
(Kodak). When necessary, purification of peptides 
was achieved by preparative paper chromatography or 
paper electrophoresis as in [ 191. 
Amino acid composition of each phosphopeptide 
was determined after hydrolysis in 6 M HCl for 24 h 
at 110°C under vacuum. Under these conditions, the 
O-ester linkage was completely hydrolyzed [22]. 
The phosphorylated sites were identified by 
sequencing the phosphopeptides by manual Edman 
degradation and measuring the radioactivity after 
each cycle involving the elimination of a serine residue. 
3. Results and discussion 
The radioautography of the peptide map of the 
tryptic hydrolysate of the individual histones and of 
the dimer H2A-H2B labelled with [32P]phosphate 
showed 2 labelled peptides in histone H2Aa, 4 in his- 
tone H2B and 5 in the complex H2A-H2B and in 
histone H5. 
Structural studies of the phosphorylated tryptic 
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Table 1 
Sites of in vitro phosphorylation of histones 
Histones sequences of 32 P-labelled tryptlc peptides Amounts of phosphorylatlcna 
T-l 
T-2b 
Dlmer H2A-HZB T-3 
T-4 
T-5' 
P 
I 
N-acetyl-Ser-Gly-Arg (from H2A) 25 
1 
7 P 
(LH;-Arg)-So;-Thr-Ile-Thr-ler-rlrg (from HZB) 4 
91 
'; 
Ser-Arg-Ser-Ser-Arg (from HZA) 25 
19 
! 
(Lys)-Glu-SW-Tyr-SW-Val-Tyr-Val-Tyr-Lys (from HZB) 13 
34 36 
Lys-Arg-Ser-Arg (from HZB) 33 
32 
H5 
P 
I 
T-l Ser-Arg 24 
145 
P P 
T-2 (A;~-Arg)-S~;-Ala-Ser-His-Pro-Thr-Tyr-S~~-Glu-Met-Ile-Ala-Ala-Ala-Ile-Arg 20 
T-3 Lys-Ala-SW-Lys 17 
166 
I 
T-4 Lys-Ala-SW-Lys-Ala-Lys-Lys 13 
166 
P 
I 
T-5 Lys-Lys-Ser-Arg 26 
145 
a The amounts of phosphorylation are expressed in % of the total amount of [a*P]phosp*hate incorporated into the proteins 
b Residues in parentheses are not included in the tryptic peptides. They are written to show that the phosphorylation sites are 
P 
placed in a sequence B-X-Ser where B is a basic amino acid, X any amino acid 
c In the dime1 H2A-H2B, the bond ArgJ, -Ser,, is not cleaved: this accounts for the presence of 5 radioactive spots (2 from his- 
tone H2A and 3 from histone H2B) instead of 6, on the radioautography of the peptide map whereas in histone H2B the 
P 
cleavage of this bond generates peptide Ser,, -Arg,, [lo] 
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peptides isolated by chromatography on Dowex-50 
allowed us to identify the sites of phosphorylation in 
each protein (table 1). 
Two serine residues (Seri and Serrg) were phos- 
phorylated in rat chloroleukemia histone H2A-cll. 
The presence of a phosphate group on Ser,s com- 
pletely inhibits the cleavage of the ArgiT-Serra bond 
by trypsin and results in the peptide: 
9 
Serr6--Arg-Ser-Ser-Argle 
We must emphasize that the change Thr -+ Ser 
at position 16 of the amino acid sequence of rat his- 
tone H2A by comparison with the homologous calf 
histone, does not introduce a third site of phosphoryl- 
ation in histone H2A. 
Seri was also found phosphorylated in vivo in 
trout testis [23] and rat liver [24] histone H2A. 
On the other hand, Serrs was the only site of in 
vitro phosphorylation identified in calf thymus his- 
tone H2A phosphorylated with the catalytic subunit 
of the cyclic AMP-dependent histone kinase isolated 
from pig brain [25]. 
Four sites of phosphorylation were identified in 
rat thymus histone H2B: Sersz and Serw as major 
sites; Sera, and Serai as minor sites [lo]. The incom- 
plete cleavage by trypsin of the bond Argar-Seraz 
7 
generated peptide Lysae-Arg-Ser-Argss together 
with peptide Seraa-Argss and consequently 
accounted for the presence of two radioactive spots 
corresponding to [32P]Ser32 on the peptide map of 
histone H2B. 
When the dimer H2A-H2B was phosphorylated, 
the presence of a true dimer in the experimental con- 
ditions of phosphorylation was ascertained by cir- 
cular dichroism spectroscopy (fig.1). Increase of 
a-helix content typical of histone-histone interac- 
tion is seen at 222 nm by comparison with individual 
histone spectra. 
In the dimer H2A-H2B, the sites of phosphoryla- 
tion were found identical to those determined in the 
individual histones. These sites are located outside 
or at the edge of the structured apolar regions 
(18-127 of H2A and 32-125 of H2B) which 
strongly interact together to form the histone com- 
plex H2A-H2B (M. C., unpublished). The highly 
basic N-terminal regions of H2A and H2B are not 
involved in dimer formation and are major sites of 
interaction of DNA. 
Clearly, the phosphorylation sites of H2A and 
H2B are still accessible to the kinase when H2A and 
H2B interact together. 
Five radioactive peptides were identified in the 
tryptic hydrolysate of chicken erythrocyte histone 
HS. One peptide corresponding to the sequence 
22-37 of the protein contained two sites of phospho- 
rylation (Ser22 and Ser29). The third serine residue 
present in the peptide at position 24 was not phos- 
phorylated. The amount of radioactivity measured in 
this peptide represents -20% of the total labelling 
of the protein. The remainder of the radioactivity 
is equally distributed between Serras and Seriee in 
the highly basic C-terminal half of the histone H5. 
Due to incomplete cleavage by trypsin of the 
susceptible bonds adjacent to the phosphorylated 
sites, the labelled Seriqs and Serr, were each identi- 
fied in two different peptides (table 1). However, 
since the peptide Ser-Arg can be generated by 
tryptic hydrolysis of the Lys-Ser bond present 3 
times in the amino acid sequence of histone H5 
(residues 40-42; residues 144-146; residues 161- 
163), it was necessary to ascertain the position of the 
9 
peptide Ser-Arg in the sequence of the protein. 
Phosphorylated histone H5 was therefore hydrolysed 
by pepsin in order to yield the C-terminal half of 
the protein (residues 94-189) by specific cleavage of 
the Pheg3-Argw bond. The tryptic digestion of this 
peptide generated peptides: 
P 
Lys-Lys-Serr4s-Arg; Lys-Ala-Ser166-Lys; 
No peptide Ser-Arg was found in the tryptic digest 
of the peptic peptides originating from the amino- 
terminal half of the histone H5. 
The sites of phosphorylation of chicken histone 
H5 identified here are different from those found in 
the homologous protein from pigeon erythrocyte 
[26]. The in vitro phosphorylation of pigeon histone 
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H5 with a pig brain protein kinase occurred at Serb5 
(or Ser&, SerdP, Sergl (or Serg2) and at a serine or 
threonine residue in the carboxy-terminal half of the 
molecule. The protein kinase from pig brain seems 
therefore to have a specificity different from that of 
the protein kinase from rat pancreas. This difference 
of specificity has already been pointed out in the 
phosphorylation of histone H2B [lo]. 
However, the in vitro phosphorylation sites of his- 
tone H5 are different from those of the in vivo phos- 
phorylation [27]. In vivo, Serg and Ser, are strongly 
32P-labelled to the same specific activity. In the 
carboxy-terminal part of the molecule (residues 
12 l-1 89), the two serine residues phosphorylated in 
vivo have not been identified with certainty but they 
appear to be different from the in vitro sites (Serlds 
and Serl&. 
Our results show that the phosphorylation of his- 
tone HS occurs mainly in the strongly basic carboxy- 
terminal region of the molecule where 80% of the 
total amount of radioactivity are incorporated. The 
remaining 32P-label is found in the slightly basic 
N-terminal part of the molecule at the edge of the 
globular region of the protein (residues 23-99) [28]. 
However, even if the specificity is different from 
one kinase to another, the sites of phosphorylation in 
histone HS are distributed in vitro or in vivo, in two 
distinct regions of the protein: the basic carboxy- 
terminal region and the apolar amino-terminal region. 
Phosphorylation of the histones H2A, H2B and HS 
by the cyclic AMP-dependent protein kinase isolated 
from rat pancreas occurs generally on serine residue 
located in a sequence B-X-Ser where B is Lys or 
Arg and X any amino acid (table 1). However, phos- 
phorylation of Serl in H2A, Sergl in H2B and Serzs 
in HS does not meet with this code, but it must be 
stated that Sergl in H2B and Ser,, in H5 are minor 
phosphorylation sites. The phosphorylated Ser3* in 
H2B and Ser1g5 in HS on the one hand and Ser,, in 
H2A and Serlh6 in H5, on the other hand, are located 
in strongly homologous sequences, respectively. 
The recognition of specific amino acid sequences 
by the protein kinase is completed by that of a spe- 
cific secondary structure. Indeed, all the phosphoryla- 
tion sites are located within regions predicted as 
o-turns [12,13]. 
Phosphorylation essentially takes place in the 
highly basic regions of the histones involved in elec- 
trostatic interactions with the phosphate groups of 
DNA. The 3 minor sites (Sers, and Sergl in H2B, 
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and Serz9 in H5) which are located inside the struc- 
tured apolar regions of the proteins [28,29], are 
brought to the surface of the protein by a &turn 
structure and therefore are accessible to the protein 
kinase [ 131. The major sites of phosphorylation are 
placed outside the organised apolar regions of the 
proteins [29]. 
The fact that Ser, and Serlg in H2A and Ser3* 
and Ser,, in H2B are phosphorylated in the histone 
complex H2A-H2B is in conformity with that 
determination. 
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